Found: 6
Select item for more details and to access through your institution.
PEGylated Domain I of Beta-2-Glycoprotein I Inhibits Thrombosis in a Chronic Mouse Model of the Antiphospholipid Syndrome.
- Published in:
- Frontiers in Immunology, 2022, v. 13, p. 1, doi. 10.3389/fimmu.2022.842923
- By:
- Publication type:
- Article
066 What are the most important issues facing women with RA in pregnancy?
- Published in:
- 2019
- By:
- Publication type:
- Abstract
022 Both Domain I and PEGylated Domain I of Beta-2-Glycoprotein I (β2GPI) are capable of inhibiting IgA APS antibody binding.
- Published in:
- 2019
- By:
- Publication type:
- Abstract
Structural and Biophysical Insights into SPINK1 Bound to Human Cationic Trypsin.
- Published in:
- International Journal of Molecular Sciences, 2022, v. 23, n. 7, p. 3468, doi. 10.3390/ijms23073468
- By:
- Publication type:
- Article
PEGylated Domain I of Beta-2-Glycoprotein I Inhibits the Binding, Coagulopathic, and Thrombogenic Properties of IgG From Patients With the Antiphospholipid Syndrome.
- Published in:
- Frontiers in Immunology, 2018, p. N.PAG, doi. 10.3389/fimmu.2018.02413
- By:
- Publication type:
- Article
Digital PCR Analysis of Maternal Plasma for Noninvasive Detection of Sickle Cell Anemia.
- Published in:
- Clinical Chemistry, 2012, v. 58, n. 6, p. 1025, doi. 10.1373/clinchem.2011.178939
- By:
- Publication type:
- Article